These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 19562272

  • 1. Copper and zinc in the serum, urine, and hair of patients with Wilson's disease treated with penicillamine and zinc.
    Dastych M, Procházková D, Pokorný A, Zdrazil L.
    Biol Trace Elem Res; 2010 Mar; 133(3):265-9. PubMed ID: 19562272
    [Abstract] [Full Text] [Related]

  • 2. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM.
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [Abstract] [Full Text] [Related]

  • 3. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
    Brewer GJ, Dick RD, Yuzbasiyan-Gurkan V, Johnson V, Wang Y.
    J Lab Clin Med; 1994 Jun; 123(6):849-58. PubMed ID: 8201263
    [Abstract] [Full Text] [Related]

  • 4. Wilson's disease: assessment of D-penicillamine treatment.
    Van Caillie-Bertrand M, Degenhart HJ, Luijendijk I, Bouquet J, Sinaasappel M.
    Arch Dis Child; 1985 Jul; 60(7):652-5. PubMed ID: 4026361
    [Abstract] [Full Text] [Related]

  • 5. Low-dose zinc administration as an effective Wilson's disease treatment.
    Najda J, Stella-Hołowiecka B, Machalski M.
    Biol Trace Elem Res; 2001 Jun; 80(3):281-4. PubMed ID: 11508632
    [Abstract] [Full Text] [Related]

  • 6. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC, Mestriner C, Irato P, Albergoni V, Longo G, D'Incà R.
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [Abstract] [Full Text] [Related]

  • 7. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F, Cardin R, D'inca R, Naccarato R, Sturniolo GC.
    J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of Wilson's disease with zinc. 5 cases].
    Bona I, Broussolle E, Neuschwander P, Confavreux C, Fontanges T, Accominotti M, Chazot G.
    Rev Neurol (Paris); 1993 Jun; 149(6-7):393-7. PubMed ID: 8303158
    [Abstract] [Full Text] [Related]

  • 9. Contribution to the data on copper concentration in blood and urine in patients with Wilson's disease and in normal subjects.
    Lech T, Sadlik JK.
    Biol Trace Elem Res; 2007 Jul; 118(1):16-20. PubMed ID: 17848726
    [Abstract] [Full Text] [Related]

  • 10. The treatment of Wilson's disease with zinc. IV. Efficacy monitoring using urine and plasma copper.
    Brewer GJ, Hill G, Prasad A, Dick R.
    Proc Soc Exp Biol Med; 1987 Apr; 184(4):446-55. PubMed ID: 3562454
    [Abstract] [Full Text] [Related]

  • 11. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z, Heyrovský A, Volek V.
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [Abstract] [Full Text] [Related]

  • 12. Zinc sulphate therapy for Wilson's disease after acute deterioration during treatment with low-dose D-penicillamine.
    Veen C, van den Hamer CJ, de Leeuw PW.
    J Intern Med; 1991 Jun; 229(6):549-52. PubMed ID: 2045766
    [Abstract] [Full Text] [Related]

  • 13. [Serum levels of zinc, copper and selenium in patients with Wilson's disease treated with zinc].
    Dastych M.
    Vnitr Lek; 1999 Apr; 45(4):217-9. PubMed ID: 11045182
    [Abstract] [Full Text] [Related]

  • 14. Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease.
    Vieira J, Oliveira PV, Juliano Y, Warde KR, Deguti MM, Barbosa ER, Carrilho FJ, Cancado EL.
    Dig Liver Dis; 2012 Apr; 44(4):323-7. PubMed ID: 22169274
    [Abstract] [Full Text] [Related]

  • 15. [Urine copper determination in Wilson's disease during therapy].
    Schnack H.
    Wien Z Inn Med; 1967 Apr; 48(12):469-76. PubMed ID: 5620588
    [No Abstract] [Full Text] [Related]

  • 16. Results of treatment of Wilson's disease--own observations.
    Jabłońska-Kaszewska I, Drobińska-Jurowiecka A, Dabrowska E, Trocha H.
    Med Sci Monit; 2003 Aug; 9 Suppl 3():9-14. PubMed ID: 15156603
    [Abstract] [Full Text] [Related]

  • 17. Oral zinc sulphate for Wilson's disease.
    Van Caillie-Bertrand M, Degenhart HJ, Visser HK, Sinaasappel M, Bouquet J.
    Arch Dis Child; 1985 Jul; 60(7):656-9. PubMed ID: 4026362
    [Abstract] [Full Text] [Related]

  • 18. Zinc therapy in Wilson's disease: observations in five patients.
    Rossaro L, Sturniolo GC, Giacon G, Montino MC, Lecis PE, Schade RR, Corazza GR, Trevisan C, Naccarato R.
    Am J Gastroenterol; 1990 Jun; 85(6):665-8. PubMed ID: 2353684
    [Abstract] [Full Text] [Related]

  • 19. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V, Di Leo V, Lamboglia F, Bowlus CL, Tseng SC, D'Incà R, Irato P, Burra P, Martines D, Sturniolo GC.
    Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
    [Abstract] [Full Text] [Related]

  • 20. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G, Keidl E, Hütteroth T, Dormeyer HH, Manns M, Meyer zum Büschenfelde KH.
    Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.